Janna Hachmann
COO and Co-founder @Captain T Cell
Signup · Get unlimited contacts
WORK HISTORY
COO and Co-founder @Captain T Cell
Berlin, DE
Captain T Cell develops first-in-class, efficacy-enhanced T cell therapies against solid tumors that are not addressed by existing treatments. Captain T Cell generates next-generation TCR-T cells with enhanced persistence and the capacity to cope with the hostile tumor microenvironment of difficult-to-treat solid tumors. In addition, the Company has established a novel allogeneic platform to enable off-the-shelf treatments of solid tumors. Captain T Cell was founded by a dedicated team of immuno-oncology experts using technology developed at the Max Delbrück Center, Berlin, Germany.
EDUCATION
Freie Universität Berlin
Master of Science, Biochemistry
Sanford-Burnham Graduate School of Biomedical Sciences
Doctor of Philosophy (Ph.D.) in Biomedical Sciences, Biomedical Sciences, General
Scripps Research
Master's thesis, Biochemistry
SKILLS
ABOUT JANNA HACHMANN
I am a curious and outgoing biochemist with a passion for meaningful biotech ventures that drive innovation in healthcare.As the COO and co-founder of Captain T Cell, I lead company operations and am involved in a wide range of management activities, including business development, strategic growth, and investor relations. Captain T Cell is pioneering next-generation, efficacy-enhanced T cell therapies for solid tumor patients who lack treatment options. One of our key innovations is a novel allogeneic platform designed to enable off-the-shelf T cell therapies. Originally a spin-off from the Max Delbrück Center in Berlin, Captain T Cell is now an independent company advancing cutting-edge immunotherapies.I hold a Ph.D. in Biomedical Sciences from Sanford Burnham Prebys Medical Discovery Institute in La Jolla, CA. My career has spanned roles in antibody discovery at InhibRx (San Diego), healthcare consulting for BMBF-funded projects, and technology transfer at the Berlin Institute of Health. At BIH, I helped shape Berlin Health Innovations, designing funding programs and commercialization strategies to accelerate the translation of research into market-ready solutions. These experiences have given me a deep understanding of both the scientific and operational aspects of bringing new biotech innovations to market.I thrive at the intersection of science, strategy, and entrepreneurship—driving innovations that make a real impact.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.